Yeo Han-koo: "U.S. Pharmaceutical Tariffs Have Limited Short-term Impact...We Must Remain Vigilant"
Ministry of Trade and Ministry of Health Hold Meeting with Pharmaceutical Exporters on April 6
Yeohan Gu, Director General for Trade Negotiations at the Ministry of Trade, Industry and Energy, commented on the U.S. tariff measures on pharmaceuticals on the 6th, stating, "For Korea, a 15% tariff will be applied in accordance with the Korea-U.S. tariff agreement. However, biosimilars, one of our major export items, are exempt from tariffs for one year, so the short-term impact is expected to be limited."
The Ministry of Trade, Industry and Energy and the Ministry of Health and Welfare held a meeting in Seoul on this day regarding the U.S. pharmaceutical Section 232 tariffs, bringing together five major pharmaceutical export companies—Samsung Biologics, Celltrion, Daewoong Pharmaceutical, SK Biopharmaceuticals, and Lotte Biologics—along with relevant associations and support organizations.
Hyun-Koo Yeo, Director General for Trade Negotiations at the Ministry of Trade, Industry and Energy (center), is presiding over the "Pharmaceutical Export Companies Meeting" held on the 6th in Seoul, attended by related ministries such as the Ministry of Health and Welfare, support organizations, and key pharmaceutical export companies and association representatives. Ministry of Trade, Industry and Energy
View original imageThe U.S. government has decided to impose, in principle, a 100% tariff on patented pharmaceuticals and raw materials under this measure. However, for pharmaceuticals produced in countries with which the U.S. has trade agreements—such as Korea, Japan, and the European Union (EU)—a 15% tariff will be applied. In addition, generic drugs, biosimilars, and related raw materials will be exempt from tariffs for one year.
At the meeting, Director General Gu emphasized, "The United States is the largest export market for our pharmaceuticals, so it is necessary to closely examine the potential impact of these measures on the industry. As a new 15% tariff is being introduced where there was previously no tariff, and since we cannot predict additional trade actions by the U.S. in the future, we must remain vigilant."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
He added, "Since the actual impact may vary by product and by company, the government will listen as much as possible to the industry's concerns on the ground and prepare necessary countermeasures. The government will continue to communicate closely with the industry, closely monitor follow-up developments in the U.S., and proactively respond so that our companies are not placed at a disadvantage compared to major competing countries."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.